{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:30Z","timestamp":1761513750770,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.clbc.2018.07.020","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T00:29:11Z","timestamp":1532824151000},"page":"e1373-e1379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Ola S.","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa I.","family":"Shabayek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mae M.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba G.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia O.","family":"Makhlouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2018.07.020_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"year":"2013","series-title":"GLOBOCAN (2013) v1.1, Cancer Incidence and Mortality Worldwide","key":"10.1016\/j.clbc.2018.07.020_bib2"},{"key":"10.1016\/j.clbc.2018.07.020_bib3","first-page":"437971","article-title":"Cancer incidence in Egypt: results of the national population-based cancer registry program","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"J\u00a0Cancer Epidemiol"},{"key":"10.1016\/j.clbc.2018.07.020_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/cancers2041771","article-title":"Breast cancer: surgery at the South Egypt Cancer Institute","volume":"2","author":"Salem","year":"2010","journal-title":"Cancer (Basel)"},{"key":"10.1016\/j.clbc.2018.07.020_bib5","first-page":"31","article-title":"Breast cancer statistics, 2015: convergence of incidence rates between black and white women","volume":"66","author":"Desantis","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2018.07.020_bib6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2018.07.020_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1634\/theoncologist.2014-0372","article-title":"Defining breast cancer intrinsic subtypes by quantitative receptor expression","volume":"20","author":"Cheang","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2018.07.020_bib8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1200\/JCO.2012.44.8027","article-title":"Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer","volume":"31","author":"Rimawi","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2018.07.020_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bjc.2013.756","article-title":"Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study","volume":"110","author":"Purdie","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2018.07.020_bib10","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2018.07.020_bib11","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.5858\/arpa.2012-0670-OA","article-title":"Review of estrogen receptor, progesterone receptor, and HER-2\/neu immunohistochemistry impacts on treatment for a small subset of breast cancer patients transferring care to another institution","volume":"137","author":"Jorns","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clbc.2018.07.020_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clbc.2018.07.020_bib13","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/thno.11543","article-title":"MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer","volume":"5","author":"Bertoli","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.clbc.2018.07.020_bib14","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1021\/ac5028929","article-title":"Distribution profiling of circulating microRNAs in serum","volume":"86","author":"Ashby","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/j.clbc.2018.07.020_bib15","first-page":"1117","article-title":"Circulating miRNAs: promising biomarkers of human cancer","volume":"12","author":"Qu","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clbc.2018.07.020_bib16","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2018.07.020_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2012.11.001","article-title":"MicroRNAs as potential biomarkers in human solid tumors","volume":"329","author":"Shen","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2018.07.020_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1568009611313020010","article-title":"The miR-183\/96\/182 cluster regulates oxidative apoptosis and sensitizes cells to chemotherapy in gliomas","volume":"13","author":"Tang","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.clbc.2018.07.020_bib19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2018.07.020_bib20","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ijc.24827","article-title":"Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma","volume":"126","author":"Schaefer","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2018.07.020_bib21","doi-asserted-by":"crossref","first-page":"e18286","DOI":"10.1371\/journal.pone.0018286","article-title":"MicroRNA expression signatures of bladder cancer revealed by deep sequencing","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.07.020_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1349-7006.2010.01816.x","article-title":"MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology","volume":"102","author":"Yamada","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clbc.2018.07.020_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s13058-014-0473-z","article-title":"MiR-183\/-96\/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration","volume":"16","author":"Li","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2018.07.020_bib24","doi-asserted-by":"crossref","first-page":"e55272","DOI":"10.1371\/journal.pone.0055272","article-title":"The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis","volume":"8","author":"van de Bunt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.07.020_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/en.2012-1744","article-title":"Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice","volume":"154","author":"Erener","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.clbc.2018.07.020_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2012.10.021","article-title":"Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma","volume":"531","author":"Chang","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clbc.2018.07.020_bib27","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/onc.2011.500","article-title":"MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in\u00a0vitro and in\u00a0vivo","volume":"31","author":"He","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2018.07.020_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/cr.2010.79","article-title":"MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2","volume":"20","author":"Ding","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.clbc.2018.07.020_bib29","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-08-3131","article-title":"MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma","volume":"15","author":"Avissar","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2018.07.020_bib30","doi-asserted-by":"crossref","first-page":"e48692","DOI":"10.1371\/journal.pone.0048692","article-title":"Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers","volume":"7","author":"Jonsdottir","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.07.020_bib31","first-page":"195","article-title":"Evaluation of the level of knowledge of Egyptian women of breast cancer and its risk factors. A cross sectional study","volume":"53","author":"Allam","year":"2012","journal-title":"J\u00a0Prev Med Hyg"},{"key":"10.1016\/j.clbc.2018.07.020_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1634\/theoncologist.2010-0103","article-title":"Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease","volume":"15","author":"Heneghan","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2018.07.020_bib33","first-page":"950201","article-title":"MicroRNAs as novel biomarkers for breast cancer","volume":"2009","author":"Heneghan","year":"2009","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.clbc.2018.07.020_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1261\/rna.034926.112","article-title":"MicroRNA-182-5p targets a network of genes involved in DNA repair","volume":"19","author":"Krishnan","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.clbc.2018.07.020_bib35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/onc.2013.65","article-title":"Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis","volume":"33","author":"Lei","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2018.07.020_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2013.06.012","article-title":"MicroRNA \u201csignature\u201d during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention","volume":"339","author":"Munagala","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clbc.2018.07.020_bib37","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1074\/jbc.M109.031427","article-title":"Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells","volume":"284","author":"Guttilla","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clbc.2018.07.020_bib38","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3892\/ol.2013.1593","article-title":"Higher expression of circulating miR-182 as a novel biomarker for breast cancer","volume":"6","author":"Wang","year":"2013","journal-title":"Oncology Lett"},{"key":"10.1016\/j.clbc.2018.07.020_bib39","doi-asserted-by":"crossref","first-page":"e111877","DOI":"10.1371\/journal.pone.0111877","article-title":"MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome","volume":"9","author":"Medimegh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.07.020_bib40","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.18632\/oncotarget.13542","article-title":"MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer","volume":"8","author":"Zhan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2018.07.020_bib41","doi-asserted-by":"crossref","first-page":"e87032","DOI":"10.1371\/journal.pone.0087032","article-title":"Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer","volume":"9","author":"McDermott","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.07.020_bib42","first-page":"107","article-title":"[Research progress in the function of microRNA-182]","volume":"68","author":"Dong","year":"2016","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.clbc.2018.07.020_bib43","doi-asserted-by":"crossref","first-page":"e39011","DOI":"10.1371\/journal.pone.0039011","article-title":"MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2018.07.020_bib44","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1158\/0008-5472.CAN-10-1318","article-title":"Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells","volume":"70","author":"de Souza Rocha Simonini","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2018.07.020_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13148-016-0198-1","article-title":"Hsa-miR-375 is a predictor of local control in early stage breast cancer","volume":"8","author":"Zehentmayr","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.clbc.2018.07.020_bib46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/ijc.28563","article-title":"The emerging role of miR-375 in cancer","volume":"135","author":"Yan","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2018.07.020_bib47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/modpathol.2016.30","article-title":"Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer","volume":"29","author":"Canlorbe","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clbc.2018.07.020_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1479-5876-11-57","article-title":"A\u00a0systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells","volume":"11","author":"Luo","year":"2013","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.clbc.2018.07.020_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apha.12681","article-title":"MicroRNAs in metabolism","volume":"219","author":"Vienberg","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.clbc.2018.07.020_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.orcp.2015.07.011","article-title":"Exenatide reverses dysregulated microRNAs in high-fat diet-induced obese mice","volume":"10","author":"Lee","year":"2016","journal-title":"Obes Res Clin Pract"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918302325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918302325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:17:35Z","timestamp":1761513455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820918302325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1526820918302325"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2018.07.020","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2018.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}